The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants

被引：10
|
作者：
Raz, Michal Ariela [1 ]
Arnason, Jon [2 ,3 ]
Bairey, Osnat [4 ,5 ]
Shvidel, Lev [6 ]
Aviv, Ariel [7 ,8 ]
Ben Baruch, Sharon [9 ]
Perry, Chava [5 ,9 ]
Sarid, Nadav [5 ,9 ]
Kirgner, Ilya [5 ,9 ]
Dvid, Varon [5 ,9 ]
Herishanu, Yair [5 ,9 ]
Avivi, Irit [5 ,9 ]
机构：
[1] Tel Aviv Univ, Sourasky Med Ctr, Dept Internal Med T, Div Internal Med, Tel Aviv, Israel
[2] Beth Israel Deaconess Med Ctr, Dept Hematol Oncol, Boston, MA 02215 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Rabin Med Ctr, Dept Hematol, Petah Tiqwa, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[6] Rehovot & Hebrew Univ Jerusalem, Kaplan Med Ctr, Dept Hematol, Jerusalem, Israel
[7] HaEmek Med Ctr, Dept Hematol, Afula, Israel
[8] Technion Israel, Fac Med, Inst Technol, Haifa, Israel
[9] Tel Aviv Sourasky Med Ctr, Dept Hematol, Tel Aviv, Israel
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷 / 02期
关键词：
ibrutinib; direct oral anticoagulants; bleeding risk;
D O I：
10.1111/bjh.16422
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E31 / E33
页数：3
相关论文
共 50 条
  • [1] Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants
    Adam, Luise
    Feller, Martin
    Syrogiannouli, Lamprini
    Del-Giovane, Cinzia
    Donze, Jacques
    Baumgartner, Christine
    Segna, Daniel
    Floriani, Carmen
    Roten, Laurent
    Fischer, Urs
    Aeschbacher, Stefanie
    Moschovitis, Giorgio
    Schlapfer, Jurg
    Shah, Dipen
    Amman, Peter
    Kobza, Richard
    Schwenkglenks, Matthias
    Kuehne, Michael
    Bonati, Leo H.
    Beer, Jurg
    Osswald, Stefan
    Conen, David
    Aujesky, Drahomir
    Rodondi, Nicolas
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (04) : 931 - 940
  • [2] Severity of gastrointestinal bleeding is similar for patients receiving direct oral anticoagulants and patients receiving vitamin K antagonists
    Alcala-Gonzalez, Luis G.
    Jimenez, Cesar
    Cortina, Vicente
    Jimenez, Alba
    Cerda, Maria
    Johansson, Erik
    Olivera, Pavel
    Santamaria, Amparo
    Alonso-Cotoner, Carmen
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (10) : 599 - 604
  • [3] Direct oral anticoagulants for stroke prevention and risk of bleeding
    Kawada, Tomoyuki
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2025, 124 (02) : 198 - 198
  • [4] Diltiazem, direct oral anticoagulants, and risk of major bleeding in patients with atrial fibrillation
    Ang, Song Peng
    Krittanawong, Chayakrit
    Chia, Jia Ee
    Patel, Shreya
    Mukherjee, Debabrata
    HEART RHYTHM, 2024, 21 (12) : 2455 - 2457
  • [5] Vitamin K and direct oral anticoagulants in patients with major bleeding: Risk assessment
    Kawada, Tomoyuki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 235 : 199 - 199
  • [6] Association between direct oral anticoagulants and risk of gastrointestinal bleeding
    Chen, I. -Wen
    Kao, Chia -Li
    Ho, Chun-Ning
    Hung, Kuo-Chuan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 144 - 145
  • [7] Risk factors associated with intracranial bleeding and neurosurgery in patients with mild traumatic brain injury who are receiving direct oral anticoagulants
    Turcato, Gianni
    Zaboli, Arian
    Zannoni, Massimo
    Ricci, Giorgio
    Zorzi, Elisabetta
    Ciccariello, Laura
    Tenci, Andrea
    Pfeifer, Norbert
    Maccagnani, Antonio
    Bonora, Antonio
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 43 : 180 - 185
  • [8] Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants
    Benamouzig, Robert
    Guenoun, Maxime
    Deutsch, David
    Fauchier, Laurent
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) : 973 - 989
  • [9] Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants
    Robert Benamouzig
    Maxime Guenoun
    David Deutsch
    Laurent Fauchier
    Cardiovascular Drugs and Therapy, 2022, 36 : 973 - 989
  • [10] Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)
    Sebastian Werth
    Tomás Breslin
    Fionnuala NiAinle
    Jan Beyer-Westendorf
    American Journal of Cardiovascular Drugs, 2015, 15 : 235 - 242
12345